Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD

This Phase 3 clinical trial is testing Buagafuran capsules — a potential new treatment for generalized anxiety disorder (GAD) — to confirm whether it is effective and safe. GAD is a condition where people experience excessive, difficult-to-control worry about everyday events for most days over at least six months. **You may be eligible if...** - You are between 18 and 65 years old - You have been formally diagnosed with generalized anxiety disorder (GAD) - Your anxiety is severe enough to need medication - You are seen as an outpatient (not hospitalized) - You are willing and able to participate in the full trial **You may NOT be eligible if...** - You have serious depression in addition to anxiety (depression score above 17) - You have a high suicide risk - Your anxiety improved significantly between screening and baseline (20% or more reduction in score) - You are currently in another drug clinical trial - You have major heart, liver, or kidney problems Talk to your doctor to see if this trial is right for you.